Revolution Medicines
Revolution Medicines

Director, Medical Affairs, Netherlands

TLDR

Define local medical strategy for an oncology portfolio, lead launch readiness, and build Netherlands Medical Affairs processes and teams.

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

Reporting to the Country Manager Netherlands, the Medical Director, Netherlands is the medical leader responsible for defining and executing the local medical strategy RevMed portfolio and launches. This role serves as the medical voice within the Netherlands Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.

This leader will ensure that Netherlands medical considerations are embedded in the regional medical strategy and plans and will partner with the Country Manager and crossfunctional teams, as well as the Sr Dir Medical Affairs Midsized Markets and VP Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Netherlands medical team and work closely with the Midsized Markets crossfuncitonal and cross-country teams, Global and Regional Medical Affairs teams across Med Affairs functions.

Required Skills, Experience and Education:

  • Act as the Medical Affairs lead for Netherlands, accountable for local medical strategy, execution, and impact across the oncology portfolio.

  • Translate global medical and clinical strategies into locally relevant medical plans aligned with country regulations and clinical practice.

  • Build and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies.

  • Lead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level.

  • Collaborate effectively with Midsized Markets, Regional and Global teams by contributing to overall medical affairs strategy, strongly partnering with local, regional and global clinical development and operations teams.

  • Drive local medical strategy across pre-launch, launch, and post-launch phases.

  • Provide local medical expertise on evidence generation activities including local studies, real-world evidence initiatives, and investigator-initiated research (where permitted).

  • Ensure effective execution of publication plans and scientific communication activities.

  • Lead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans.

  • Partner with Market Access and Commercial teams to support value communication and reimbursement-related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings.

  • Support lifecycle management activities including new indications, label updates, and competitive positioning.

  • Work closely with Market Access, Commercial, Regulatory, Safety, and Corporate Affairs teams to ensure aligned and compliant execution of country plans.

  • Provide medical review and approval of non-promotional materials in accordance with local regulations and company policies.

  • Build, lead, and develop the country Medical Affairs team when/if applicable, including Medical advisors and MSLs.

  • Establish medical processes, governance, and ways of working as part of the country build-out.

  • Foster a culture of scientific rigor, compliance, and collaboration.

  • Ensure all medical activities comply with local regulations, national and regional codes, and internal company policies.

  • Represent Medical Affairs in country governance and risk management forums.

  • Advanced degree required (MD, PhD, or PharmD).

  • Strong background and experience in oncology required.

  • 10+ years’ experience in Medical Affairs with a track record of country leadership.

  • Proven value and benefit assessment experience, with deep understanding of Netherlands payer decision-making.

  • Strong stakeholder management and ability to collaborate with internal and external partners.

  • Proven experience supporting oncology product launches in Netherlands.

  • Strong understanding of the local healthcare system, clinical practice, and regulatory environment.

  • Experience in a biotech and/or in a build-out.

  • Excellent communication skills, both in person and virtual.

  • Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment.

  • Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.

  • Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.

  • Willingness to travel nationally and internationally.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com

#LI-Hybrid #LI-LO1

We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
 
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
 
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.

Benefits

Remote-Friendly

Fully remote role

Revolution Medicines is a late-stage clinical oncology company focused on developing targeted therapies for patients with RAS-addicted cancers. Our innovative R&D pipeline features RAS(ON) inhibitors tailored to suppress various oncogenic variants of RAS proteins, setting us apart in the fight against difficult-to-treat cancers.

Founded
Founded 2014
Employees
500+ employees
Industry
biotechnology
Funding stage
Public
Stock ticker
Publicly traded (RVMDW)
Total raised
$4.3B raised
Last funding
Raised April 2026
View company profile